Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Matteo Carella
Observed names:
Carella, Matteo,
M Carella,
M. Carella
Observed institutions:
Sunnybrook Health Science Centre,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna,
Ospedale Policlinico San Martino,
University of Bologna
ORCID:
0000-0001-5997-6452
Observed ORCID:
0000-0001-5997-6452
OpenAlex ID:
A5065207434
Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML/RARA fusion
2021
·
Annalisa Astolfi
, Riccardo Masetti
, et al.
·
Blood
·
43
PDF
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
2024
·
Gianluca Storci
, Francesco De Felice
, et al.
·
Journal of Clinical Investigation
·
38
Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma
2020
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Cancer Medicine
·
28
PDF
Bendamustine‐rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients
2020
·
Alice Morigi
, Lisa Argnani
, et al.
·
Hematological Oncology
·
20
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experience
2021
·
Alessandro Broccoli
, Lisa Argnani
, et al.
·
American Journal of Hematology
·
19
PDF
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients
2020
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Annals of Hematology
·
11
PDF
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real‐life experience
2020
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Hematological Oncology
·
11
Single-agent rituximab is an effective salvage therapy in pretreated patients with hairy cell leukemia
2023
·
Alessandro Broccoli
, Lisa Argnani
, et al.
·
Blood Advances
·
9
PD-1 blockade as bridge to allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series
2019
·
Beatrice Casadei
, Alessandro Broccoli
, et al.
·
Haematologica
·
9
PDF
90Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma) — The Zeno Study
2020
·
Ginevra Lolli
, Lisa Argnani
, et al.
·
British Journal of Haematology
·
7
PDF
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
2022
·
Vittorio Stefoni
, Lisa Argnani
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
5
PDF
Gastro-intestinal stromal tumor (GIST): case report.
2001
·
S Occhionorelli
, M Mitaritonno
, et al.
·
PubMed
·
5
Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone Lymphoma
2024
·
Camilla Mazzoni
, Lisa Argnani
, et al.
·
European Journal Of Haematology
·
4
PDF
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice
2025
·
Cinzia Pellegrini
, Beatrice Casadei
, et al.
·
Annals of Hematology
·
3
Long-term efficacy of immune checkpoint inhibitors for relapsed primary mediastinal B-cell lymphoma: a real-world study
2025
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Blood Advances
·
2
Microenvironmental Traits of Classical Hodgkin’s Lymphoma in Adolescents and Their Prognostic Impact
2024
·
Clara Bertuzzi
, Simona Righi
, et al.
·
Cancers
·
2
PDF
90y‐ibritumomab Tiuxetan in Patients With Extra‐nodal Marginal Zone B‐cell Lymphoma of Mucosa Associated Lymphoid Tissue (malt Lymphoma) – the Zeno Study
2019
·
M. Marangon
, A. Morigi
, et al.
·
Hematological Oncology
·
2
Antigenic markers in extragonadal germ cell tumors.
1984
·
A Maiorana
, C Sannicola
, et al.
·
PubMed
·
2
SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy
2025
·
Marianna Gentilini
, Beatrice Casadei
, et al.
·
Annals of Hematology
·
1
PDF
The Treatment of Burkitt Lymphoma with the Berlin-Frankfurt-Münster Protocol with Rituximab and Autologous Transplantation
2023
·
Alessandro Broccoli
, Gianmarco Bagnato
, et al.
·
Blood
·
1
PDF
Gut microbiome in DLBCL patients undergoing first‐line R‐CHOP regimen—The Oncopassport Study
2023
·
V. Stefoni
, L. Argnani
, et al.
·
Hematological Oncology
·
1
PDF
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series
2022
·
Alessandro Broccoli
, Lisa Argnani
, et al.
·
Tumori Journal
·
1
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy
2021
·
Matteo Carella
, Vittorio Stefoni
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Multicenter experience with imatinib mesylate in 202 newly diagnosed chronic myeloid leukemia (CML) patients
2008
·
M. Carella
, E. Orlandi
, et al.
·
Journal of Clinical Oncology
·
1
Hodgkin lymphoma patients in complete remission show epigenetic remodeling in cardiac function-related genes.
2026
·
Pirazzini, Chiara
, De Matteis, Serena
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Show more works
View as search
Works count:
50
Citation count:
226
H-index:
9
I10-index:
7
Year
Topic
Type